Novartis AG

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. 0.11%82.360.7%$1556.69m
JNJJohnson & Johnson -0.04%165.700.7%$1044.17m
PFEPfizer Inc. 0.37%43.700.9%$945.42m
ABBVAbbVie, Inc. -0.08%109.321.9%$659.34m
LLYEli Lilly & Co. 0.43%249.551.1%$641.87m
BMYBristol-Myers Squibb Co. -0.16%58.121.0%$633.95m
AZNAstraZeneca Plc 0.11%62.331.0%$285.30m
NVSNovartis AG -1.75%83.350.2%$179.50m
GSKGlaxoSmithKline Plc -0.92%39.790.2%$163.74m
AVIRAtea Pharmaceuticals, Inc. 0.00%12.390.3%$123.47m
RGENRepligen Corp. 0.00%273.836.8%$109.24m
VTRSViatris, Inc. 0.30%13.520.0%$89.79m
NVONovo Nordisk A/S -1.31%105.970.1%$89.66m
SNYSanofi -1.10%49.410.2%$65.71m
OGNOrganon & Co. -0.33%36.620.0%$52.99m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.